Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder
Project Number1K23DA058015-01A1
Former Number1K23DA058015-01
Contact PI/Project LeaderSCHWEBEL, FRANK
Awardee OrganizationUNIVERSITY OF NEW MEXICO
Description
Abstract Text
Project Summary/Abstract
This Mentored Patient-Oriented Research Career Development application (K23) will provide protected time for
Dr. FrankSchwebel to strengthen his trajectory as independent researcher at the University of New Mexico,
Center on Alcohol, Substance use, And Addictions (UNM-CASAA). His goal is to develop expertise in
mindfulness-based interventions, advanced quantitative methods, and interactive, personalized mHealth
interventions to improve medication adherence and treatment outcomes among individuals struggling with
opioid use disorder (OUD) and other substance use disorders. In order to develop expertise in these areas, the
candidate proposes an innovative, mentored research study using text messages to deliver medication
adherence reminders and mindfulness-based intervention content for individuals taking medications for opioid
use disorder (MOUD). OUD and opioid overdose have increased significantly over the past 20 years and are
considered an epidemic. MOUD has proven to be an effective treatment option, however, medication
adherence is a significant problem with most dropout occurring within one month of MOUD initiation.
Mindfulness-based interventions show promise in helping decrease opioid use. This study builds on existing
literature suggesting the effectiveness of medication reminders and supplements it by focusing on factors that
might help decrease risk of opioid use (e.g., mindfulness, self-efficacy, craving, withdrawal symptoms)
(consistent with NIDA FY 2021-2025 Strategic Plan Outline Goal 2). By conducting a microrandomized trial
(MRT), the study takes an innovative approach to identify effective mindfulness-based intervention content and
is a necessary step in creating a cutting-edge, just-in-time adaptive intervention (JITAI) (consistent with NIDA
Strategic Plan Action 2.1). This mentored study will offer the necessary training to help the candidate develop
expertise to establish his own independent mHealth intervention program of research that specializes in using
mindfulness-based interventions to treat OUD. With the guidance of his mentorship team, Dr. Schwebel’s
training plan and mentored study are integrated and selected to promote the development of a comprehensive
skillset in the following areas: 1) mindfulness-based interventions for OUD (Dr. Witkiewitz [UNM]), 2)
integration of pharmacological and psychological treatments (Drs. Witkiewitz [UNM], Tofighi [NYU]), 3)
advanced mHealth approaches and user-centered design (Drs. Pearson [UNM], Murphy [Harvard], Suffoletto
[Stanford]), 4) advanced quantitative methods (Drs. Witkiewitz [UNM], Pearson [UNM], Murphy [Harvard]), and
5) professional development, dissemination, grantsmanship, and ethics (Drs. Witkiewitz [UNM], Pearson
[UNM], Murphy [Harvard], Suffoletto [Stanford], Tofighi [NYU]). In addition to training at CASAA, Dr. Schwebel
will visit Dr. Murphy’s lab at Harvard University and complete trainings at a variety of institutes across the
country (e.g., mHealth Training Institute, Penn State Methodology Center). Through this training, Dr. Schwebel
will be prepared to develop an independent research program.
Public Health Relevance Statement
Project Narrative
This project will provide Dr. FrankSchwebel with training in mindfulness-based interventions, psychosocial and
pharmacological treatment approaches for opioid use disorder, advanced mobile health approaches and
quantitative methods, and research ethics. The proposed research will evaluate the efficacy of a
microrandomized intervention designed to increase state mindfulness, decrease craving, and increase self-
efficacy among individuals who take daily medication for an opioid use disorder. Together, the well-integrated
research and career development plans will support Dr. Schwebel’s independent research program focused on
developing mobile health treatments for opioid use disorder.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAlcoholsAppointmentAreaBehavioral MechanismsBenchmarkingBiochemicalBuprenorphineCCL4 geneCountryDevelopmentDevelopment PlansDoseDropoutDrug ScreeningEffectivenessEpidemicEthicsEthnic OriginFosteringGoalsIndividualInterventionLiteratureMentorsMentorshipMethadoneMethodologyMethodsModelingNational Institute of Drug AbuseNew MexicoOpioidOverdoseParticipantPatientsPersonsPharmaceutical PreparationsPharmacological TreatmentPlacebosPoliciesPublic HealthQuestionnairesRaceResearchResearch EthicsResearch PersonnelRiskSelf EfficacyStrategic PlanningStressSubstance Use DisorderText MessagingTimeTrainingTreatment outcomeUnited StatesUniversitiesUrineVisitWithdrawal Symptomacceptability and feasibilityacute careadaptive interventionaddictionadherence ratebehavior changecareer developmentcost efficientcravingeffective therapyefficacy evaluationeligible participantimprovedimproved outcomeinnovationintervention effectintervention programmHealthmedication compliancemedication for opioid use disordermedication nonadherencemeetingsmhealth interventionsmindfulnessmindfulness interventionmultilevel analysisopioid overdoseopioid useopioid use disorderoverdose deathoverdose preventionpatient oriented researchpharmacologicprogramspsychologicpsychosocialrandomized, clinical trialsrecruitresearch and developmentresearch studyresponseretention ratesatisfactionsex as a biological variableskillssubstance usesynthetic opioidtherapy designtreatment comparisonuser centered designwaiver
No Sub Projects information available for 1K23DA058015-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K23DA058015-01A1
Patents
No Patents information available for 1K23DA058015-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K23DA058015-01A1
Clinical Studies
No Clinical Studies information available for 1K23DA058015-01A1
News and More
Related News Releases
No news release information available for 1K23DA058015-01A1
History
No Historical information available for 1K23DA058015-01A1
Similar Projects
No Similar Projects information available for 1K23DA058015-01A1